LSTA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Lisata Therapeutics Inc (LSTA) is not a strong buy at this moment for a beginner investor with a long-term strategy. The stock lacks significant positive catalysts, has no recent trading signals, and faces potential risks with the Kuva Labs takeover deal. The technical indicators are neutral to slightly bullish, but the lack of clear growth trends and negative analyst sentiment suggest holding off on investment for now.
The MACD is slightly positive at 0.0255 and contracting, RSI is neutral at 56.67, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). Key support and resistance levels are Pivot: 3.611, R1: 3.893, S1: 3.328, R2: 4.068, S2: 3.153. However, the stock's trend suggests a 60% chance of minor gains in the next day but declines in the next week (-3.94%) and month (-7.43%).
NULL identified. No recent news or significant insider/hedge fund activity.
H.C. Wainwright downgraded the stock to Neutral due to increased risk of the Kuva Labs takeover deal not closing. No recent congress trading data or positive sentiment from analysts.
No financial data available for analysis.
H.C. Wainwright downgraded the stock to Neutral from Buy, citing risks in the Kuva Labs takeover deal. No price target provided.
